THE PROGNOSTIC VALUE OF KI67 IMMUNOSTAINING IN NON-HODGKINS LYMPHOMA

被引：328

作者：

HALL, PA

RICHARDS, MA

GREGORY, WM

DARDENNE, AJ

LISTER, TA

STANSFELD, AG

机构：

[1] ST BARTHOLOMEWS HOSP, DEPT HISTOPATHOL, LONDON EC1A 7BE, ENGLAND

[2] ST BARTHOLOMEWS HOSP, IMPERIAL CANC RES FUND, DEPT MED ONCOL, LONDON EC1A 7BE, ENGLAND

[3] UNIV LONDON UNIV COLL, CLIN OPERAT RES UNIT, LONDON WC1E 6BT, ENGLAND

来源：

JOURNAL OF PATHOLOGY | 1988年 / 154卷 / 03期

关键词：

D O I：

10.1002/path.1711540305

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：223 / 235

页数：13

共 52 条

[1]

BAISCH H, IN PRESS CELL TISSUE

[2] PROLIFERATIVE INDEX IN BREAST-CARCINOMA DETERMINED INSITU BY KI67 IMMUNOSTAINING AND ITS RELATIONSHIP TO CLINICAL AND PATHOLOGICAL VARIABLES [J].

BARNARD, NJ ;

HALL, PA ;

LEMOINE, NR ;

KADAR, N .

JOURNAL OF PATHOLOGY, 1987, 152 (04) :287-295

[3] UPTAKE OF THYMIDINE IN LYMPHOMA-CELLS OBTAINED THROUGH FINE-NEEDLE ASPIRATION BIOPSY - RELATION TO PROGNOSIS IN NON-HODGKINS LYMPHOMAS [J].

BRANDT, L ;

OLSSON, H ;

MONTI, M .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1981, 17 (11) :1229-1233

[4] PERCENTAGE OF CELLS IN THE S-PHASE OF THE CELL-CYCLE IN HUMAN LYMPHOMA DETERMINED BY FLOW-CYTOMETRY - CORRELATION WITH LABELING INDEX AND PATIENT SURVIVAL [J].

BRAYLAN, RC ;

DIAMOND, LW ;

POWELL, ML ;

HARTYGOLDER, B .

CYTOMETRY, 1980, 1 (03) :171-174

[5] THE USE OF THE MONOCLONAL-ANTIBODY KI-67 IN THE IDENTIFICATION OF PROLIFERATING CELLS - APPLICATION TO SURGICAL NEUROPATHOLOGY [J].

BURGER, PC ;

SHIBATA, T ;

KLEIHUES, P .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1986, 10 (09) :611-617

[6]

COOPER EH, 1976, EUR J CANCER, V4, P287

[7]

COSTA A, 1981, J NATL CANCER I, V66, P1

[8]

DHALIWAL HS, 1984, 2ND INT C MAL LYMPH

[9]

DIAMOND LW, 1982, CANCER-AM CANCER SOC, V50, P1122, DOI 10.1002/1097-0142(19820915)50:6<1122::AID-CNCR2820500616>3.0.CO

[10]

2-Q

← 1 2 3 4 5 6 →